Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) R&D Expenses & History | Stock Alarm

Demo Sign up Log In

Teva Pharmaceutical Industries Limited American Depositary Shares · R&D Expenses

TEVA R&D Expenses

Latest reported$995.00Mperiod endingJun 30, 2026

TEVA R&D Expenses ($0.00 → $995.00M)

Annual R&D Expenses

High-resolution chart · PNG

TEVA r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	1,013,000,000
Dec 31, 2024	1,055,000,000
Dec 31, 2023	953,000,000
Dec 31, 2022	838,000,000
Dec 31, 2021	1,094,000,000
Dec 31, 2020	1,794,000,000
Dec 31, 2019	1,010,000,000
Dec 31, 2018	1,213,000,000
Dec 31, 2017	1,848,000,000
Dec 31, 2016	2,111,000,000
Dec 31, 2015	1,525,000,000
Dec 31, 2014	1,488,000,000
Dec 31, 2013	1,427,000,000
Dec 31, 2012	1,356,000,000
Dec 31, 2011	1,095,000,000
Dec 31, 2010	933,000,000
Dec 31, 2009	802,000,000
Dec 31, 2008	786,000,000
Dec 31, 2007	581,000,000
Dec 31, 2006	495,000,000
Dec 31, 2005	368,900,000
Dec 31, 2004	338,400,000
Dec 31, 2003	213,500,000
Dec 31, 2002	165,000,000
Dec 31, 2001	107,273,000
Dec 31, 2000	104,575,000
Dec 31, 1999	81,842,000
Dec 31, 1998	68,100,000
Dec 31, 1997	65,200,000
Dec 31, 1996	62,800,000
Dec 31, 1995	31,600,000
Dec 31, 1994	36,600,000
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0
Dec 31, 1989	0
Dec 31, 1988	0
Dec 31, 1986	0
Dec 31, 1985	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.